Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial on TopotectTM (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

NCT00548561 is registered in ClinicalTrials.gov with Valerio Therapeutics as lead sponsor.

NCT NCT00548561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00548561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial on TopotectTM (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents
Lead sponsor
Valerio Therapeutics
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2001
Completion date
July 31, 2003
Enrollment
23 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

anthracycline extravasation